- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 5/078 - Cells from blood or from the immune system
Patent holdings for IPC class C12N 5/078
Total number of patents in this class: 3259
10-year publication summary
|
177
|
229
|
277
|
294
|
326
|
257
|
299
|
256
|
241
|
144
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Iovance Biotherapeutics, Inc. | 405 |
92 |
| Kyoto University | 2923 |
45 |
| Megakaryon Corporation | 51 |
38 |
| FATE Therapeutics, Inc. | 235 |
33 |
| Fenwal, Inc. | 704 |
31 |
| Rubius Therapeutics, Inc. | 62 |
31 |
| The Board of Trustees of the Leland Stanford Junior University | 6687 |
29 |
| The Regents of the University of California | 20815 |
27 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3275 |
24 |
| Cellphire, Inc. | 109 |
23 |
| University Health Network | 1066 |
20 |
| The Trustees of the University of Pennsylvania | 4423 |
19 |
| President and Fellows of Harvard College | 6105 |
18 |
| Massachusetts Institute of Technology | 10282 |
17 |
| Board of Regents, The University of Texas System | 6141 |
17 |
| Children's Medical Center Corporation | 1963 |
17 |
| STEMCELL Technologies Canada Inc. | 301 |
17 |
| The Trustees of Columbia University in the City of New York | 3644 |
16 |
| Cellectis | 415 |
16 |
| Memorial Sloan-Kettering Cancer Center | 2051 |
16 |
| Other owners | 2713 |